AbbVie (NYSE:ABBV) posted fourth-quarter earnings in line with analysts’ consensus forecast. The firm repeated its recent long-term guidance.  The North Chicago, Ill.-based biopharmaceutical company, reported revenues of $13.9 billion — a 59% increase over the prior year. The quarter’s net income was $36 million, or $0.01 per share. That was considerably less than the earnings…